Clinical Trials for CLL/SLL

Find clinical trials for cll/sll. Discover research opportunities and treatment options in your area.

13 Active Trials Found

Showing 13 trials on this page

Page 1 of 1

LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This

NCT ID: NCT06978088

This clinical trial is studying a new combination treatment called LP-168 and Obinutuzumab for patients with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) who have already ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Cincinnati, Ohio, United States

Study of Epcoritamab as a Consolidation Therapy in CLL/SLL

NCT ID: NCT07108998

This clinical trial is studying a new treatment called Epcoritamab for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), which are types of blood cancers. The tria...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Cincinnati, Ohio, United States

Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL

NCT ID: NCT04215809

This clinical trial is studying a new medication called APG-2575 to see if it is safe and effective for treating chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL). The trial is...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jacksonville, Florida, United States, Duarte, California, United States +7 more

French Observational Study of Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in Real-World Settings

NCT ID: NCT05590702

This clinical trial is studying how patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) are treated in everyday medical settings. The goal is to understand the real...

Recruiting

Type: observational Locations: Angers, , France, Villejuif, , France +56 more

Current Status of BTKi Treatment for CLL/SLL in China

NCT ID: NCT06508684

This clinical trial is looking at how well a type of treatment called BTK inhibitors is working for patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) in China. B...

Recruiting

Type: observational Locations: Nanjin, Jiangsu, China

A Practical Clinical Study Comparing the Fixed-cycle Regimen Containing Orelabrutinib With BTKi Monotherapy

NCT ID: NCT06476899

This clinical trial is studying a new treatment approach for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The goal is to compare a specific combination of m...

Not yet recruiting

Phase: PHASE2 Type: interventional

A Global Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.

NCT ID: NCT06319456

This clinical trial is investigating a new treatment approach for patients with newly diagnosed Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL). The study is comparing the ef...

Recruiting

Phase: PHASE3 Type: interventional Locations: Guangzhou, Guangdong, China, Guangzhou, Guangdong, China +4 more

Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With Relapsed or Refractory CLL or SLL

NCT ID: NCT05791409

This clinical trial is studying a new treatment approach for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have not responded to previous therapies. The t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Antwerpen, , Belgium, Antwerpen, , Belgium +23 more

Global Trial in APG2575 for Patients With CLL/SLL

NCT ID: NCT06104566

This clinical trial is studying a new treatment for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The trial is testing a medication called APG2575, which is ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Kaluga, , Russian Federation

Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.

NCT ID: NCT04775745

This clinical trial is studying a new medication called LP-168, which is being tested for patients with certain types of blood cancers known as B-cell malignancies, including chronic lymphocytic le...

Recruiting

Phase: PHASE1 Type: interventional Locations: Columbus, Ohio, United States, Cincinnati, Ohio, United States +2 more

A Study of Orelabrutinib in CLL/SLL Patients Who Are Slowly Responding to Ibrutinib

NCT ID: NCT05491044

This clinical trial is studying a new medication called orelabrutinib for patients with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) who have been taking another drug call...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China, Beijing, Beijing, China

Clinical Study of Orelabrutinib Combined With BG Regimen First-line Treatment of CLL/SLL

NCT ID: NCT05918276

This clinical trial is studying a new treatment approach for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have not yet received treatment. The researcher...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Changsha, Hunan, China, Wuhan, Hubei, China

REtreatment With VEnetoclax and Acalabrutinib After Venetoclax Limited Duration (REVEAL)

NCT ID: NCT04523428

The REVEAL clinical trial is studying the effectiveness of a new treatment combination for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have previously r...

Recruiting

Phase: PHASE2 Type: interventional Locations: Aarhus, , Denmark, Amsterdam, , Netherlands +16 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions